Temporal lobe epilepsy and cavernous malformations

surgical strategies and long-term outcomes

Fernando Vale Diaz, Andrew C. Vivas, Jotham Manwaring, Mike R. Schoenberg, Selim R. Benbadis

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: Cerebral cavernous malformations (CCM) of the temporal lobe often present with seizures. Surgical resection of these lesions can offer durable seizure control. There is, however, no universally accepted methodology for assessing and surgically treating these patients. We propose an algorithm to maximize positive surgical outcomes (seizure control) while minimizing post-surgical neurological deficit. Methods: A retrospective review of 34 patients who underwent epilepsy surgery for radiographically proven temporal lobe CCM was conducted. Patients underwent a relatively standard work-up for seizure localization. In patients with mesial temporal lobe epilepsy (MTLE), a complete resection of the epileptogenic zone was performed including amygdalo-hippocampectomy in addition to a lesionectomy if not contraindicated by pre-operative work-up. Patients with neocortical epilepsy underwent intraoperative electrocorticography (ECoG)-guided lesionectomy. Results: Seizure-free rate for mesial and neocortical (anterior, lateral, and basal) location was 90 vs. 83 %, respectively. Complete resection of the lesion, irrespective of location, was statistically significant for seizure control (p = 0.018). There was no difference in seizure control based on disease duration or location (p > 0.05). Patients with mesial temporal CCM who presented with MTLE were presumed to also have mesial temporal sclerosis (MTS), or dual pathology. These patients underwent routine resection of the mesial structures. Interestingly, patients who had MTLE and basal (neocortical) lesions who underwent a mesial resection for suspected MTS were found not to have dual pathology. Conclusions: Patients with temporal lobe CCM should be offered resection for durable seizure control, prevention of secondary epileptogenic foci, and elimination of hemorrhage risk. The preoperative work-up should follow a team approach. Surgical intervention should include complete lesionectomy in all cases. Intra or extra-operative ECoG for neocortical lesions may be beneficial. Management of mesial temporal CCMs (archicortex) should consider resection of a well-defined epileptogenic zone (including mesial structures) due to high probability of pathologically proven MTS. The use of this treatment algorithm is useful for the education and treatment of these patients.

Original languageEnglish (US)
Pages (from-to)1887-1895
Number of pages9
JournalActa Neurochirurgica
Volume157
Issue number11
DOIs
StatePublished - Nov 1 2015
Externally publishedYes

Fingerprint

Temporal Lobe Epilepsy
Seizures
Central Nervous System Cavernous Hemangioma
Sclerosis
Temporal Lobe
Epilepsy
Pathology
Patient Education
Secondary Prevention
Hemorrhage

Keywords

  • Cavernous malformation
  • Epilepsy
  • Pathology
  • Temporal lobe

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Temporal lobe epilepsy and cavernous malformations : surgical strategies and long-term outcomes. / Vale Diaz, Fernando; Vivas, Andrew C.; Manwaring, Jotham; Schoenberg, Mike R.; Benbadis, Selim R.

In: Acta Neurochirurgica, Vol. 157, No. 11, 01.11.2015, p. 1887-1895.

Research output: Contribution to journalArticle

Vale Diaz, Fernando ; Vivas, Andrew C. ; Manwaring, Jotham ; Schoenberg, Mike R. ; Benbadis, Selim R. / Temporal lobe epilepsy and cavernous malformations : surgical strategies and long-term outcomes. In: Acta Neurochirurgica. 2015 ; Vol. 157, No. 11. pp. 1887-1895.
@article{5b4b44a74d8f4a17ad71b69ba3bae560,
title = "Temporal lobe epilepsy and cavernous malformations: surgical strategies and long-term outcomes",
abstract = "Objective: Cerebral cavernous malformations (CCM) of the temporal lobe often present with seizures. Surgical resection of these lesions can offer durable seizure control. There is, however, no universally accepted methodology for assessing and surgically treating these patients. We propose an algorithm to maximize positive surgical outcomes (seizure control) while minimizing post-surgical neurological deficit. Methods: A retrospective review of 34 patients who underwent epilepsy surgery for radiographically proven temporal lobe CCM was conducted. Patients underwent a relatively standard work-up for seizure localization. In patients with mesial temporal lobe epilepsy (MTLE), a complete resection of the epileptogenic zone was performed including amygdalo-hippocampectomy in addition to a lesionectomy if not contraindicated by pre-operative work-up. Patients with neocortical epilepsy underwent intraoperative electrocorticography (ECoG)-guided lesionectomy. Results: Seizure-free rate for mesial and neocortical (anterior, lateral, and basal) location was 90 vs. 83 {\%}, respectively. Complete resection of the lesion, irrespective of location, was statistically significant for seizure control (p = 0.018). There was no difference in seizure control based on disease duration or location (p > 0.05). Patients with mesial temporal CCM who presented with MTLE were presumed to also have mesial temporal sclerosis (MTS), or dual pathology. These patients underwent routine resection of the mesial structures. Interestingly, patients who had MTLE and basal (neocortical) lesions who underwent a mesial resection for suspected MTS were found not to have dual pathology. Conclusions: Patients with temporal lobe CCM should be offered resection for durable seizure control, prevention of secondary epileptogenic foci, and elimination of hemorrhage risk. The preoperative work-up should follow a team approach. Surgical intervention should include complete lesionectomy in all cases. Intra or extra-operative ECoG for neocortical lesions may be beneficial. Management of mesial temporal CCMs (archicortex) should consider resection of a well-defined epileptogenic zone (including mesial structures) due to high probability of pathologically proven MTS. The use of this treatment algorithm is useful for the education and treatment of these patients.",
keywords = "Cavernous malformation, Epilepsy, Pathology, Temporal lobe",
author = "{Vale Diaz}, Fernando and Vivas, {Andrew C.} and Jotham Manwaring and Schoenberg, {Mike R.} and Benbadis, {Selim R.}",
year = "2015",
month = "11",
day = "1",
doi = "10.1007/s00701-015-2592-4",
language = "English (US)",
volume = "157",
pages = "1887--1895",
journal = "Acta Neurochirurgica",
issn = "0001-6268",
publisher = "Springer Wien",
number = "11",

}

TY - JOUR

T1 - Temporal lobe epilepsy and cavernous malformations

T2 - surgical strategies and long-term outcomes

AU - Vale Diaz, Fernando

AU - Vivas, Andrew C.

AU - Manwaring, Jotham

AU - Schoenberg, Mike R.

AU - Benbadis, Selim R.

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Objective: Cerebral cavernous malformations (CCM) of the temporal lobe often present with seizures. Surgical resection of these lesions can offer durable seizure control. There is, however, no universally accepted methodology for assessing and surgically treating these patients. We propose an algorithm to maximize positive surgical outcomes (seizure control) while minimizing post-surgical neurological deficit. Methods: A retrospective review of 34 patients who underwent epilepsy surgery for radiographically proven temporal lobe CCM was conducted. Patients underwent a relatively standard work-up for seizure localization. In patients with mesial temporal lobe epilepsy (MTLE), a complete resection of the epileptogenic zone was performed including amygdalo-hippocampectomy in addition to a lesionectomy if not contraindicated by pre-operative work-up. Patients with neocortical epilepsy underwent intraoperative electrocorticography (ECoG)-guided lesionectomy. Results: Seizure-free rate for mesial and neocortical (anterior, lateral, and basal) location was 90 vs. 83 %, respectively. Complete resection of the lesion, irrespective of location, was statistically significant for seizure control (p = 0.018). There was no difference in seizure control based on disease duration or location (p > 0.05). Patients with mesial temporal CCM who presented with MTLE were presumed to also have mesial temporal sclerosis (MTS), or dual pathology. These patients underwent routine resection of the mesial structures. Interestingly, patients who had MTLE and basal (neocortical) lesions who underwent a mesial resection for suspected MTS were found not to have dual pathology. Conclusions: Patients with temporal lobe CCM should be offered resection for durable seizure control, prevention of secondary epileptogenic foci, and elimination of hemorrhage risk. The preoperative work-up should follow a team approach. Surgical intervention should include complete lesionectomy in all cases. Intra or extra-operative ECoG for neocortical lesions may be beneficial. Management of mesial temporal CCMs (archicortex) should consider resection of a well-defined epileptogenic zone (including mesial structures) due to high probability of pathologically proven MTS. The use of this treatment algorithm is useful for the education and treatment of these patients.

AB - Objective: Cerebral cavernous malformations (CCM) of the temporal lobe often present with seizures. Surgical resection of these lesions can offer durable seizure control. There is, however, no universally accepted methodology for assessing and surgically treating these patients. We propose an algorithm to maximize positive surgical outcomes (seizure control) while minimizing post-surgical neurological deficit. Methods: A retrospective review of 34 patients who underwent epilepsy surgery for radiographically proven temporal lobe CCM was conducted. Patients underwent a relatively standard work-up for seizure localization. In patients with mesial temporal lobe epilepsy (MTLE), a complete resection of the epileptogenic zone was performed including amygdalo-hippocampectomy in addition to a lesionectomy if not contraindicated by pre-operative work-up. Patients with neocortical epilepsy underwent intraoperative electrocorticography (ECoG)-guided lesionectomy. Results: Seizure-free rate for mesial and neocortical (anterior, lateral, and basal) location was 90 vs. 83 %, respectively. Complete resection of the lesion, irrespective of location, was statistically significant for seizure control (p = 0.018). There was no difference in seizure control based on disease duration or location (p > 0.05). Patients with mesial temporal CCM who presented with MTLE were presumed to also have mesial temporal sclerosis (MTS), or dual pathology. These patients underwent routine resection of the mesial structures. Interestingly, patients who had MTLE and basal (neocortical) lesions who underwent a mesial resection for suspected MTS were found not to have dual pathology. Conclusions: Patients with temporal lobe CCM should be offered resection for durable seizure control, prevention of secondary epileptogenic foci, and elimination of hemorrhage risk. The preoperative work-up should follow a team approach. Surgical intervention should include complete lesionectomy in all cases. Intra or extra-operative ECoG for neocortical lesions may be beneficial. Management of mesial temporal CCMs (archicortex) should consider resection of a well-defined epileptogenic zone (including mesial structures) due to high probability of pathologically proven MTS. The use of this treatment algorithm is useful for the education and treatment of these patients.

KW - Cavernous malformation

KW - Epilepsy

KW - Pathology

KW - Temporal lobe

UR - http://www.scopus.com/inward/record.url?scp=84944037102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944037102&partnerID=8YFLogxK

U2 - 10.1007/s00701-015-2592-4

DO - 10.1007/s00701-015-2592-4

M3 - Article

VL - 157

SP - 1887

EP - 1895

JO - Acta Neurochirurgica

JF - Acta Neurochirurgica

SN - 0001-6268

IS - 11

ER -